Hong Kong Stock Exchange disclosures reveal that on August 14, The Goldman Sachs Group, Inc. increased its holdings in Asymchem (06821) by 44,100 shares at an average price of HK$116.3827 per share, totaling approximately HK$5.1325 million.
Following this transaction, the investment bank's latest share count in the pharmaceutical company stands at roughly 1.4201 million shares, representing a 5.1% ownership stake.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.